Blockchain Registration Transaction Record

Hagens Berman Urges Edwards Lifesciences Corporation (NYSE: EW) Investors Who Suffered Substantial Losses to Submit Their Losses Now

Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit their losses now. The class action lawsuit is focused on the propriety of Edwards Lifesciences’ disclosures about its core product, the Transcatheter Aortic Valve Replacement (“TAVR”) platform.

This news matters as it highlights a class action lawsuit against Edwards Lifesciences Corporation for allegedly misleading investors about the true business and growth prospects for TAVR, impacting shareholder value and investor trust.